Carisma Therapeutics, Inc. (CARM) NASDAQ

0.44

+0.225(+104.65%)

Updated at September 02 04:00PM

Currency In USD

Valuation

Market Cap17.36M
Enterprise Value1.93M
P/E Ratio-0.37
PEG Ratio-0.11
Price/Sales Ratio1.71
Price/Book Ratio-0.4
Enterprise/Revenue1.68
Enterprise/EBITDA-0.43

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-4.59
Operating Margin-4.28

Management Effectiveness

Return On Assets-9.85
Return On Equity1.62

Income Statement

Revenue19.63M
Revenue/Share0.26
Gross Profit-40.04M
EBITDA-57.12M
Net Income-60.48M
Diluted EPS-1.46

Balance Sheet

Total Cash2M
Total Cash/Share0.05
Total Debt1.7M
Total Debt/Equity-0.04
Current Ratio0.48
Book Value Per Share-1.1

Price History

52-Week Change-56
52-Week High1.27
52-Week Low0.14
Moving Average 50 Days0.34
Moving Average 200 Days0.41

Statistics

Average Volume15.71M
Shares Outstanding41.79M
% Held by Institutions9.5

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:20
Last Split DateMarch 08, 2023